Clinical trial
L-Theanine in the Management of Schizophrenia
NCT00372151 · Sha'ar Menashe Mental Health Center, Other · Completed
Key facts
| NCT number | NCT00372151 |
|---|---|
| Title | L-Theanine in the Management of Schizophrenia |
| Official title | The Value of Augmenting L-Theanine in the Management of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
| Lead sponsor | Sha'ar Menashe Mental Health Center, Other |
| Collaborators | Stanley Medical Research Institute Beersheva Mental Health Center |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Dietary Supplement, Other |
| Interventions | L-Theanine, Placebo |
| Enrollment | 60 |
| Start date | Oct 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 6, 2006 |
| Last update posted | Dec 16, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: